Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immune Response Corp
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Immune Response Corp since year 2005.
Table 2 shows the detailed insider transactions of Immune Response Corp since 2005.
The reporting company's ticker symbol is IMNR. The reporting company's CIK number is 817785.
The total value of stock buying since 2005 is $98,880.
The total value of stock sales since 2005 is $21,936,244.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2006-11-09||Green Michael K (COO and CFO)||Sale||2,474,900||1.92||4,751,808|
|2006-11-08||Green Michael K (COO and CFO)||Sale||1,770,000||1.90||3,363,000|
|2006-11-07||Green Michael K (COO and CFO)||Sale||325,600||1.91||621,896|
|2006-11-06||Green Michael K (COO and CFO)||Sale||158,000||1.91||301,780|
|2006-11-03||Green Michael K (COO and CFO)||Sale||1,042,500||1.92||2,001,600|
|2006-11-02||Green Michael K (COO and CFO)||Sale||1,041,000||1.96||2,040,360|
|2006-11-01||Green Michael K (COO and CFO)||Sale||333,000||1.95||649,350|
|2006-10-31||Green Michael K (COO and CFO)||Sale||355,000||1.99||706,450|
|2006-10-19||Theofan Georgia (VP, Clinical Development)||Sale||720,000||2.00||1,440,000|
|2006-09-15||Theofan Georgia (VP, Clinical Development)||Sale||150,000||2.00||300,000|
|2006-09-08||Theofan Georgia (VP, Clinical Development)||Sale||2,180,000||2.00||4,360,000|
|2006-08-31||Theofan Georgia (VP, Clinical Development)||Sale||200,000||2.00||400,000|
|2006-08-29||Theofan Georgia (VP, Clinical Development)||Sale||250,000||2.00||500,000|
|2006-08-25||Theofan Georgia (VP, Clinical Development)||Sale||250,000||2.00||500,000|
|2006-08-21||Hochman David P (Director)||Buy||500,000||.02||9,000|
|2006-07-28||Hochman David P (Director)||Buy||2,600,000||.02||59,800|
|2006-07-27||Hochman David P (Director)||Buy||300,000||.02||6,600|
|2006-06-19||Hochman David P (Director)||Buy||200,000||.02||4,000|
|2005-09-22||Kimberlin Kevin (10% Owner)||Buy||9,643,060||.00||0|
|2005-09-06||Green Michael K (VP, Finance and CFO)||Buy||30,000||.50||14,880|
|2005-09-02||Bonfiglio John N (CEO)||Buy||10,000||.46||4,600|
Insider trading activities including stock purchases, stock sales, and option exercises of IMNR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immune Response Corp (symbol IMNR, CIK number 817785) see the Securities and Exchange Commission (SEC) website.